pubmed-article:9076386 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9076386 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:9076386 | lifeskim:mentions | umls-concept:C0683325 | lld:lifeskim |
pubmed-article:9076386 | lifeskim:mentions | umls-concept:C0264716 | lld:lifeskim |
pubmed-article:9076386 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
pubmed-article:9076386 | lifeskim:mentions | umls-concept:C0205100 | lld:lifeskim |
pubmed-article:9076386 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:9076386 | pubmed:dateCreated | 1997-5-23 | lld:pubmed |
pubmed-article:9076386 | pubmed:abstractText | The peripheral chemoreflex may be augmented in chronic heart failure and may play a role in its pathophysiology including the mediation of exercise hyperpnoea and sympathetic activation. The objective of this study was to characterize the patients with an augmented peripheral chemoreflex. | lld:pubmed |
pubmed-article:9076386 | pubmed:language | eng | lld:pubmed |
pubmed-article:9076386 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9076386 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9076386 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9076386 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9076386 | pubmed:month | Mar | lld:pubmed |
pubmed-article:9076386 | pubmed:issn | 0195-668X | lld:pubmed |
pubmed-article:9076386 | pubmed:author | pubmed-author:HarringtonDD | lld:pubmed |
pubmed-article:9076386 | pubmed:author | pubmed-author:CoatsA JAJ | lld:pubmed |
pubmed-article:9076386 | pubmed:author | pubmed-author:PiepoliMM | lld:pubmed |
pubmed-article:9076386 | pubmed:author | pubmed-author:PonikowskiPP | lld:pubmed |
pubmed-article:9076386 | pubmed:author | pubmed-author:ChouT JTJ | lld:pubmed |
pubmed-article:9076386 | pubmed:author | pubmed-author:AnkerS DSD | lld:pubmed |
pubmed-article:9076386 | pubmed:author | pubmed-author:Webb-PeploeKK | lld:pubmed |
pubmed-article:9076386 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9076386 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:9076386 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9076386 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9076386 | pubmed:pagination | 480-6 | lld:pubmed |
pubmed-article:9076386 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:meshHeading | pubmed-meshheading:9076386-... | lld:pubmed |
pubmed-article:9076386 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9076386 | pubmed:articleTitle | Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. | lld:pubmed |
pubmed-article:9076386 | pubmed:affiliation | Royal Brompton Hospital, London, U.K. | lld:pubmed |
pubmed-article:9076386 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9076386 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9076386 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9076386 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9076386 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9076386 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9076386 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9076386 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9076386 | lld:pubmed |